Genomics BioSci & Tech. Co.,Ltd. (TPE:4195)

Taiwan · Delayed Price · Currency is TWD

16.30

+0.45 (2.84%)

At close: Oct 8, 2026

Market Cap	1.30B -33.3%
Revenue (ttm)	718.16M +20.1%
Net Income	-25.70M
EPS	-0.35
Shares Out	80.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	107,040
Open	15.85
Previous Close	15.85
Day's Range	15.80 - 16.65
52-Week Range	12.80 - 36.85
Beta	-0.15
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 16, 2026

About Genomics BioSci & Tech.

Genomics BioSci & Tech. Co.,Ltd. operates as a genomic company in Taiwan. The company offers sequencing, synthesis, genomic, proteomic, and agency and sales services; clinical testing services, such as reproductive health and cancer testing services; and contract development and manufacturing services. The company was founded in 2001 and is based in New Taipei City, Taiwan. [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 2001

Country Taiwan

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 4195

Full Company Profile

Financial Performance

In 2025, Genomics BioSci & Tech.'s revenue was 708.38 million, an increase of 36.86% compared to the previous year's 517.58 million. Losses were -39.43 million, -82.33% less than in 2024.

Financial Statements